Akèy › Kansè pankreyas › Utah › West Valley City
Etid klinik pou Kansè pankreyas nan West Valley City, UT
12 etid pou Kansè pankreyas ap chèche patisipan nan sit nan ak bò kote West Valley City (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Ap rekriteFaz 1
- START Mountain Region, West Valley City
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Ap rekriteFaz 1
- START Mountain Region, LLC, West Valley City
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
Ap rekriteFaz 1
- START Mountain Region, West Valley City
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
Ap rekriteFaz 2
- START- Mountain Region, West Valley City
A Study of MGC026 in Participants With Advanced Solid Tumors
Ap rekriteFaz 1
- START Mountain Region, West Valley City
A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors
Ap rekriteFaz 1
- START Mountain Region, West Valley City
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
Ap rekriteFaz 1
- Start Mountain Region /ID# 276270, West Valley City
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
Ap rekriteFaz 1/2
- START Mountain Region, West Valley City
A Study of MGC028 in Participants With Advanced Solid Tumors
Ap rekriteFaz 1
- South Texas Accelerated Research Therapeutics (START) Mountain Region, West Valley City
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
Ap rekriteFaz 1/2
- START Mountain Region, West Valley City
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Ap rekriteFaz 1/2
- START Mountain Region, West Valley City
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
Ap rekriteFaz 1/2
- START, Mountain Region, West Valley City
Etid Kansè pankreyas nan lòt vil
- Houston, TX61 etid
- New York City, NY60 etid
- Boston, MA43 etid
- Nashville, TN39 etid
- Los Angeles, CA35 etid
- St. Louis, MO33 etid
- Arlington, VA33 etid
- Baltimore, MD31 etid
- San Antonio, TX31 etid
- Philadelphia, PA26 etid
- Tampa, FL26 etid
- Durham, NC24 etid
Lòt etid nan West Valley City
- Kansè Poumon ki pa ti selil25 etid
- Kansè kolorektal17 etid
- Kansè nan tete13 etid
- Kansè tete negatif triple13 etid
- Kansè Metastatik13 etid
- Kansè (tout kalite)11 etid
- Kansè ovè11 etid
- Karsinòm selil skuamèz tèt ak kou11 etid
- Kansè Endomèt10 etid
- Kansè lestomak8 etid
- Kasinom Selil Skwamoz Ezofajyen7 etid
- Kansè poumon selil ti7 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.